Stock Price Quote

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE1627.55-12.5 (-0.76 %)
PREV CLOSE ( ) 1640.05
OPEN PRICE ( ) 1620.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6864
TODAY'S LOW / HIGH ( )1598.00 1685.00
52 WK LOW / HIGH ( )950.1 1845.9
NSE1628.15-14.05 (-0.86 %)
PREV CLOSE( ) 1642.20
OPEN PRICE ( ) 1612.00
BID PRICE (QTY) 1628.15 (631)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 172740
TODAY'S LOW / HIGH( ) 1596.05 1690.00
52 WK LOW / HIGH ( )955 1846
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 14-02 1995
Management Info
Arvind Lal - Chairman Arvind Lal - Managing Director
Registered Office

Address Block E,Sector 18,Rohini,
New Delhi,
Delhi-110085

Phone 91-011-3024 4149

Email ved.goel@lalpathlabs.com

Website www.lalpathlabs.com

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE

NEWS

03Feb Announcement under Regulation 30 (LOD
Please take note that the Board of Directors of the Company's Wholly Own..
03Feb Announcement under Regulation 30 (LOD
In compliance with Regulation 30 of the SEBI (Listing Obligations & Disc..
03Feb Announcement under Regulation 30 (LOD
We wish to inform you that, the Board of Directors in their meeting held..
03Feb Dr Lal Pathlabs informs about earnings
Dr Lal Pathlabs has informed that it has attached a copy of Company's Q3..
03Feb Dr Lal Pathlabs informs about press re
Dr Lal Pathlabshas informed that it has enclosed the Press Release for t..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit5111954
Gross Profit 686 2923
Operating Profit 8973292
Net Sales 310411649

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Metropolis Health. (BSE)
peergroup  1861.65 (1.30%)
M.Cap ( in Cr)9425.64
Artemis Medicare (BSE)
peergroup  205.00 (4.14%)
M.Cap ( in Cr)270.73
Tejnaksh Healthcare (BSE)
peergroup  47.40 (2.82%)
M.Cap ( in Cr)48.14
Dolphin Medical Serv (BSE)
peergroup  0.55 (0.00%)
M.Cap ( in Cr)0.83
Transgene Biotek (BSE)
peergroup  3.33 (-0.30%)
M.Cap ( in Cr)25.23

Shareholding Pattern

MUTUAL FUNDS/UTI 7.73%
PROMOTERS 56.81%
NON-INSTITUTION 12.78%
FI/BANKS/INSURANCE 0.53%
GOVERNMENT 0%
FII 0%

About Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs Ltd. was incorporated in the year 1995. Its today's share price is 1627.55. Its current market capitalisation stands at Rs 13564.8 Cr. In the latest quarter, company has reported Gross Sales of Rs. 12034.18 Cr and Total Income of Rs.12493.67 Cr. The company's management includes Archana Lal Erdmann, Anoop Singh, Somya Satsangi, Harneet Singh Chandhoke, Saurabh Srivastava, Sunil Varma, Rahul Sharma, Vandana Lal, Om Prakash Manchanda, Arvind Lal, Arvind Lal.

It is listed on the BSE with a BSE Code of 539524 , NSE with an NSE Symbol of LALPATHLAB and ISIN of INE600L01024. It's Registered office is at Block E,Sector 18,RohiniNew Delhi-110085, Delhi. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X